English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/201560
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities

AuthorsMartinez-Bosch, Neus; Rodriguez-Vida, Alejo; Juanpere, Núria; Lloreta, Josep; Rovira, Ana; Albanell, Joan; Bellmunt, Joaquim; Navarro, Pilar
Issue Date23-Apr-2019
PublisherSpringer Nature
CitationNature Reviews Urology 16: 433-445 (2019)
AbstractAdvanced prostate and bladder cancer are two outstanding unmet medical needs for urological oncologists. The high prevalence of these tumours, lack of effective biomarkers and limited effective treatment options highlight the importance of basic research in these diseases. Galectins are a family of β-galactoside-binding proteins that are frequently altered (upregulated or downregulated) in a wide range of tumours and have roles in different stages of tumour development and progression, including immune evasion. In particular, altered expression levels of different members of the galectin family have been reported in prostate and bladder cancers, which, together with the aberrant glycosylation patterns found in tumour cells and the constituent cell types of the tumour microenvironment, can result in malignant transformation and tumour progression. Understanding the roles of galectin family proteins in the development and progression of prostate and bladder cancer could yield key insights to inform the clinical management of these diseases.
Publisher version (URL)http://dx.doi.org/10.1038/s41585-019-0183-5
URIhttp://hdl.handle.net/10261/201560
DOIhttp://dx.doi.org/10.1038/s41585-019-0183-5
Identifiersdoi: 10.1038/s41585-019-0183-5
e-issn: 1759-4820
issn: 1759-4812
Appears in Collections:(IIBB) Artículos
Files in This Item:
File Description SizeFormat 
OPINION Galectins in prostate and bladder cancer.pdf1,22 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.